Chaos in Oil Markets as Saudi Arabia Discusses Scenarios to Appease Everyone

Chaos reigned as in the market amid conflicting stances on oil policy. (AFP)
Chaos reigned as in the market amid conflicting stances on oil policy. (AFP)
TT

Chaos in Oil Markets as Saudi Arabia Discusses Scenarios to Appease Everyone

Chaos reigned as in the market amid conflicting stances on oil policy. (AFP)
Chaos reigned as in the market amid conflicting stances on oil policy. (AFP)

Chaos reigned on Wednesday as Russian officials said there was a need to increase the production of the Organization of the Petroleum Exporting Countries (OPEC) and its independent producers, known as OPEC Plus, while US President Donald Trump held OPEC responsible for the rise in oil prices.

Iran, however, announced its refusal to increase OPEC production at the next meeting, while rejecting the intervention of the US president in the policy of the organization, which it sees as independent and sovereign.

Saudi Arabia is trying to satisfy everyone, those supporting the increase of production and those opposing it, by offering several scenarios to increase production that will provide many solutions but at the same time not affect the price of oil significantly, sources told Bloomberg.

Saudi Arabia is mulling different scenarios to raise production over the coming months by between 500,000 barrels and one million barrels a day, Bloomberg added.

It said that one proposal envisages a single hike of just 500,000 barrels a day. Another idea would see an immediate increase of 500,000 barrels, followed by a similar rise in the fourth quarter. The Kingdom has also shared ideas with increases of around 600,000 to 700,000 barrels a day.

In contrast, Saudi Arabia and several other OPEC members, including the United Arab Emirates and Kuwait, and non-OPEC nation Oman would prefer a gradual production boost to avoid upsetting the oil market.

Russian President Vladimir Putin and Saudi Arabian Crown Prince Mohammed bin Salman will meet in Moscow to discuss oil policy on the sidelines of the opening match of the Football World Cup, Kremlin spokesman Dmitry Peskov told reporters on Wednesday.

Peskov said the two would discuss the global oil production cut agreement, which Saudi Arabia and Russia are leading, but did not plan to discuss an exit from the deal.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.